Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
5 Perspectives on Laser Treatment in Dermatology
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Adel Haque, MD, Provides His Best Advice for New Dermatologists
Recent Povorcitinib 2b Study Shows Improved Repigmentation
2 Clarke Drive Cranbury, NJ 08512